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Is phonophobia associated with cutaneous allodynia
in migraine?
Avi Ashkenazi,1 Irene Yang,2 Aamir Mushtaq,1 Michael L Oshinsky1,2
ABSTRACT
Objective To determine whether phonophobia and
dynamic mechanical (brush) allodynia are associated in
episodic migraine (EM).
Methods Adult patients with EM were prospectively
recruited. A structured questionnaire was used to obtain
demographic and migraine related data. Phonophobia
was tested quantitatively using a real time sound
processor and psychoacoustic software. Sound stimuli
were pure tones at frequencies of 1000 Hz, 4000 Hz and
8000 Hz, delivered to both ears at increasing intensities,
until an aversive level was reached. Allodynia was
assessed by brushing the patient’s skin with a gauze pad
at different areas. Patients were tested both between
and during acute attacks. Sound aversion thresholds
(SATs) in allodynic and non-allodynic patients were
compared.
Results Between attacks, SATs were lower in allodynic
compared with non-allodynic patients, with an average
difference of 5.7 dB (p¼0.04). During acute attacks,
the corresponding average SAT difference
(allodynicenon-allodynic) was 15.7 dB (p¼0.0008).
There was a significant negative correlation between
allodynia scores and SATs, both within and between
attacks.
Conclusions The results support an association
between phonophobia and cutaneous allodynia in
migraine.
Migraine patients often report on aversion to
various sensory stimuli during an acute attack.
These include aversion to light (photophobia),
sound (phonophobia), odours (osmophobia) and
mechanical or thermal stimuli to the skin (cuta-
neous allodynia).1e3 Cutaneous allodynia has been
studied extensively in migraine.4e6 There are less
data on the characteristics and mechanisms of
phonophobia, photophobia and osmophobia in this
disease.7 8 The occurrence of aversion to stimuli of
various sensory modalities in migraine raises the
question of whether they are associated in this
disease or, alternatively, are independent phenomena.
There are currently few data regarding this question.
Phonophobia may be deﬁned as aversion to
normally non-aversive sounds. This symptom has
been reported in 70e80% of migraine patients
during an acute attack.7 9 The International
Headache Society (IHS) lists phonophobia (along
with photophobia) as one of the diagnostic
criteria of migraine.10 However, the IHS does not
provide a quantitative deﬁnition of this symptom.
The mechanisms of phonophobia in migraine, and
its relation to cutaneous allodynia, are poorly
understood.
We developed a method to evaluate quantita-
tively aversion to sound in human subjects, as
a measure of phonophobia. Using this method, we
have recently shown that migraine patients exhibit
increased aversion to sound when tested between
attacks, and that this sound aversion is further
increased during an acute attack.11
The aim of the present study was to determine
whether phonophobia and dynamic mechanical
(brush) allodynia are associated in migraine. We
hypothesised that the two phenomena would be
associated in migraine subjects.
METHODS
Patients
We prospectively recruited adult women and men,
18e65 years old, who had a diagnosis of episodic
migraine with or without aura, as deﬁned by the
IHS Headache Classiﬁcation Committee.10 Patients
were recruited from the outpatient clinic of
Jefferson Headache Center and from the population
of the Philadelphia area through advertising.
Included patients were required to have at least one
migraine attack per month, but less than 15 head-
ache days per month, for 6 months prior to enrol-
ment, and to have a normal audiogram (deﬁned as
a hearing threshold of #20 dB at the tested sound
frequencies). Exclusion criteria were: any other
headache diagnosis except for episodic tension-type
headache, as deﬁned by the IHS; use of any medi-
cation, vitamin or supplement considered or
suspected to be a headache preventive within
90 days prior to enrolment; and treatment with
occipital nerve block or any other nerve block in the
head or neck area within 30 days prior to enrolment.
Patients were recruited and examined from August
2006 to August 2007. The study was approved by
the Thomas Jefferson University Institutional
Review Board for Human Research. All participants
signed an informed consent form prior to enrolment
according to the Declaration of Helsinki.
Study protocol
An audiogram was performed at the Jefferson
Center for Balance and Hearing when patients were
not experiencing an acute headache. Eligible
patients with a normal audiogram proceeded with
the study protocol. Other than the audiogram, all
study procedures took place at the Jefferson
Headache Center. Patients were examined when
they were not experiencing an acute attack (nor
within 72 h from the time they had had an attack)
(visit 1) and when they were experiencing an acute
untreated attack (visit 2). During visit 1, patients
were interviewed using a structured questionnaire
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characteristics (frequency and duration of attacks, head pain
severity during an attack and number of years they suffered
from migraine). Patients were then tested for cutaneous allo-
dynia and, thereafter, for phonophobia. For visit 2, patients were
instructed not to take any medication for their acute migraine
attack. During that visit, patients were asked about the char-
acteristics of their current attack. Subsequently, patients were
tested for allodynia and thereafter for phonophobia. After
completion of all study procedures at visit 2, patients were given
a rescue migraine treatment by one of the investigators (AA).
Patients were instructed to inform the investigator if, at any
time, they wanted to terminate the testing due to discomfort or
for any other reason. The duration of testing at each visit was
approximately 45 min.
Phonophobia testing
Phonophobia testing was performed with the subject sitting in
a sound-proof booth (Eckel Industries, Morrisburg, Ontario,
Canada). We used a RP2.1 enhanced real time processor (Tucker-
Davis Technologies, Alachua, Florida, USA) and PSYCHRP
psychoacoustic software (Tucker-Davis Technologies) for the
test. Sound stimuli were pure tones at frequencies of 1000 Hz,
4000 Hz and 8000 Hz, delivered simultaneously to both ears
using calibrated ER3 insert earphones (Etymotic Research, Elk
Grove Village, Illinois, USA). We chose these sound frequencies
as the test stimuli because the human auditory system is most
sensitive to sounds at around 4000 Hz.12 Each sound stimulus
lasted 1.5 s and the inter-stimulus onset interval was 3 s. Initial
sound intensity was 50 dB and it was increased gradually by
increments of 5 dB/3s until an unpleasant or painful intensity
was reached, at which time the subject pressed and held
a response box button, causing the sound intensity to decrease
gradually. Once a tolerable sound intensity was reached, the
subject released the response box button, causing the sound
intensity to increase again until an unpleasant or painful
intensity was reached, repeating the testing cycle once more. A
sound aversion threshold (SAT, measured in dB) was determined
as the average of the unpleasant or painful sound intensities at
the two cycles. For safety reasons, at no time did the delivered
sound intensity exceed 110 dB. Each subject was tested for
sound aversion at the three different frequencies, starting at
1000 Hz, then at 4000 Hz and ﬁnally at 8000 Hz. There was
a 10 min between test interval for the different frequencies for
each subject. We adhered to the limits of sound exposure safety,
as recommended by the Occupational Safety and Health
Administration Noise Exposure Standards.13
Allodynia testing
We tested patients for the presence of dynamic mechanical
(brush) allodynia (BA) by lightly brushing a 434 inch gauze pad
over a 2 inch area of skin, at a rate of 2/s, for a total of 10 times,
as we described previously.5 The tested skin areas for BA were:
frontal, posterior cervical and medial forearm. BA testing was
done sequentially on both sides for each skin area. Patients were
asked to assess the degree of pain or unpleasantness (if any)
evoked by the gauze pad brushing, using a 100 mm visual
analogue scale. Allodynia score (mm) at each area ranged from
0 to 100, and the total allodynia score ranged from 0 to 600 (100
(maximal allodynia score at each skin area3 6 (number of tested
areas)). We have previously shown that healthy subjects who do
not suffer from headaches do not exhibit BA when tested using
this method.5 Therefore, in this study, a total visual analogue
scale allodynia score greater than zero was considered to reﬂect
the presence of BA. To avoid a potential bias of the examiner,
allodynia testing was performed before the computerised testing
of phonophobia.
Statistical analysis
Patient demographics were summarised using frequencies and
percentages for categorical variables and medians and ranges for
continuous variables. Mixed effects linear regression was used to
model SATs. Fixed effects were included for time of SAT testing
(visit 1 (between attacks) or visit 2 (during attacks)), sound
frequency (1000, 4000 or 8000 Hz), allodynia status (present or
absent) and all possible interactions. For each visit, we used the
mixed effects model to compare SATs in allodynic with those in
non-allodynic patients at each frequency. Mixed effects linear
regression was used to assess the relationship between SATs and
allodynia scores by visit and frequency. For purposes of regres-
sion, allodynia scores were transformed using the equation
Anew¼log10 (A+1). We calculated the Spearman rank correlation
coefﬁcient between SATs and headache severity.
A p value of <0.05 was considered to reﬂect statistical
signiﬁcance.
RESULTS
Patient demographics and migraine characteristics
Of 60 recruited patients, 38 (63%) completed the two study
visits (30 (79%) women and eight (21%) men; median age 25.5
(range 18e51) years) (table 1). Twelve (32%) had migraine with
aura and 26 (68%) had migraine without aura. Median disease
duration was 8.5 years (range 1e38 years). Median attack
frequency was 3.5 per month (range 1e9 per month) and
median headache severity during an acute untreated attack was
8 (range 4e10) on a 0e10 point verbal scale. There were no
signiﬁcant differences with regard to age, gender or migraine
characteristics between patients who completed the two visits
and those who did not.
The mean time interval between attack onset (deﬁned as the
onset of the ﬁrst attack related symptom) and testing at visit 2
was 4.262.6 h (range 1e11 h) while the mean time interval
between onset of throbbing pain and testing at visit 2 was
3.362.7 h (range 0e9 h). Between attacks, 18/60 (30%) patients
were allodynic while during an acute attack 30/38 (79%)
patients exhibited allodynia.
SATs between attacks and during attacks in allodynic and in
non-allodynic patients
Between attacks, SATs were lower in allodynic compared with
non-allodynic patients at all sound frequencies (ﬁgure 1). The
SAT difference between allodynic and non-allodynic patients,
when tested between attacks (averaged for the three frequen-
cies), was 5.7 dB (p¼0.04) (at 1000 Hz: 87.662.7 vs
93.361.8 dB, p¼0.07; at 4000 Hz: 83.362.7 vs 88.961.8 dB,
p¼0.07; and at 8000 Hz: 87.362.7 vs 93.061.8, p¼0.06).
During an acute attack, SATs were again lower in allodynic
compared with non-allodynic patients at all sound frequencies
(ﬁgure 2). The SAT difference between allodynic and non-allo-
dynic patients, when tested during an acute attack, averaged for
the three frequencies, was 15.7 dB (p¼0.0008). This difference
was highly signiﬁcant for all tested sound frequencies (at
1000 Hz: 72.162.3 vs 86.464.4 dB, p¼0.004; at 4000 Hz:
69.562.3 vs 84.564.4 dB, p¼0.003; at 8000 Hz: 71.862.3 vs
87.564.4 dB, p¼0.0004).
SATs versus allodynia scores
There was a signiﬁcant negative correlation between allodynia
scores and SATs both during and between attacks. Figure 3
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shows the SAT scores, averaged for the three frequencies, as
a function of allodynia scores at visit 2. During an acute attack,
for every 1 unit increase in the transformed allodynia score, the
mean SAT decreased by 4.6 units (p¼0.01) (ﬁgure 3). Similarly,
between attacks, for every 1 unit increase in the transformed
allodynia score, the mean SAT decreased by 5 units (p¼0.01).
Spatial distribution of allodynia and SATs
Of the 30 patients who were allodynic during the tested attack,
all had allodynia at the frontal area, 22 (73%) had allodynia at
the posterior cervical area and 15 (50%) had allodynia at the
medial forearm (since patients may have had allodynia at more
than one area, the sum of these numbers exceeds 100%). We
looked at the average SATs in patients who had allodynia at the
frontal area only (n¼6), those who had allodynia at the frontal
and the posterior cervical area but not at the medial forearm
(n¼9) and those who had allodynia at all tested skin territories
(frontal, posterior cervical and medial forearm, n¼13; two
patients did not belong to any of these groups and were not
included in this analysis). The average SATs in these groups were
70.8613.2 dB, 72.4614.2 dB and 73.868.4 dB, respectively, with
no signiﬁcant difference among the groups (KruskaleWallis test,
p¼0.59).
Subjective report of phonophobia, photophobia and osmophobia
in allodynic and in non-allodynic patients during the acute attack
During the acute attack, 90% of allodynic and 75% of non-
allodynic patients reported on phonophobia (Fisher ’s exact test,
p¼0.29). At the same time, 97% of allodynic and 88% of non-
allodynic patients reported on photophobia, (p¼0.39) and 35%
of allodynic, compared with 25% of non-allodynics, reported on
osmophobia (p¼0.69).
We further evaluated subjective phonophobia by asking the
patients to rate their sound aversion during the tested attack in
relation to that between attacks as ‘much worse’, ‘moderately
worse’, ‘minimally worse’, ‘the same’, ‘minimally improved’,
‘moderately improved’ or ‘much improved’. Of the 30 patients
who were allodynic during the tested attack, seven (23.3%) rated
their sound aversion as ‘much worse’, 16 (53.3%) rated it as
‘moderately worse’, six (20%) as ‘minimally worse’ and one
(3.3%) as ‘the same’ (ﬁgure 4). Conversely, of the eight patients
who were non-allodynic during the tested attack, none rated
their sound aversion as ‘much worse’, one (12.5%) rated it as
‘moderately worse’, six (75%) as ‘minimally worse’ and one
(12.5%) as ‘the same’ (ﬁgure 4). No patient in either group rated
their sound aversion during the acute attack as improved
compared with that between attacks. Converting these ratings
to numerical values (from 1 ¼ ‘much improved’ to 7 ¼ ‘much
worse’), the median subjective phonophobia scores of allodynic
and non-allodynic patients during the tested attack were 6.0 and
5.0, respectively (Wilcoxon rank sum test, p¼0.001).
SATs versus migraine characteristics
SATswere non-signiﬁcantly lower in patients withmigrainewith
aura compared with those who had migraine without aura, both
between attacks (88.461.2 vs 92.761.7, p¼0.08) and within
attacks (73.761.9 vs 77.761.8, p¼0.18).During attacks, therewas
a non-signiﬁcant negative correlation between SATs and headache
severity: the average acute attack SAT decreased by 1.8 dB for
every unit increase in acute headache severity (p¼0.28).
Table 1 Demographics and disease characteristics of the patients who completed the two visits
Allodynic Non-allodynic Total p Value
Gender (n (%))
Men 6 (20.0) 2 (25.0) 8 (21.1) 1.00
Women 24 (80.0) 6 (75.0) 30 (78.9)
Age (years) 26.5 (18, 51) 26.5 (18, 50) 25.5 (18, 51) 0.86
Disease duration (years) 9 (1, 35) 10 (4, 38) 8.5 (1, 38) 0.72
Attack frequency (per month) 3.3 (1, 9) 4 (1, 9) 3.5 (1, 9) 0.28
Headache severity during an attack
(scale: 0e10)
8 (4, 10) 6.5 (4, 10) 8 (4, 10) 0.19
Aura (n (%)) 11 (36.7) 1 (12.5) 12 (31.6) 0.39
Data on continuous variables are presented as medians (min, max).
Patients were defined as allodynic or non-allodynic based on their allodynia status during the tested attack.
Figure 1 Sound aversion thresholds (mean (SEM)) between attacks in
non-allodynic and allodynic patients.
Figure 2 Sound aversion thresholds (mean (SEM)) during an acute
attack in non-allodynic and allodynic patients.
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DISCUSSION
We found that migraine patients who exhibited brush allodynia
during an acute attack were also more aversive to sound (ie,
phonophobic), as demonstrated by lower SATs, compared with
non-allodynic patients. These results suggest an association
between phonophobia and allodynia in migraine.
Phonophobia has long been recognised in migraine.9 14 In
a study by Kayan and Hood, phonophobia was subjectively
reported by 81% of 200 migraine patients during an acute
attack.9 The authors suggested a peripheral mechanism to this
symptomdspeciﬁcally, a transient disturbance of function of
the cochlear receptors. This hypothesis has been challenged by
others.7 8 Few studies have examined phonophobia in migraine
in a quantitative manner.2 7 8 Vanagaite Vingen et al found
increased aversion to sound in migraineurs compared with
controls, both between and during attacks.7 The authors
suggested a central mechanism for phonophobia in migraine,
possibly mediated by noradrenergic or serotonergic pathways.15
In accordance with these results, Main et al reported on
increased hearing discomfort in migraine patients between
attacks.2 Woodhouse and Drummond found an increase in both
auditory and visual discomfort in migraineurs during attacks.8
They suggested a centrally mediated hyperexcitability of the
special senses during attacks as the underlying mechanism. In
none of these studies was the association between phonophobia
and cutaneous allodynia examined.
The presence of increased aversion to stimuli of multiple
sensory modalities (eg, sound, light, touch) in migraine raises the
hypothesis that they are associated through a central integrative
mechanism rather than generated separately by dysfunction of
multiple distinct afferent pathways. Our demonstration of
association between two of these phenomena (phonophobia and
allodynia) lends support to this hypothesis. It is interesting that
the reported prevalence of phonophobia in migraine is remark-
ably similar to that of allodynia (up to 80% in some studies),
further supporting (albeit not proving) their association.9 16
To test for phonophobia, we used sound stimuli at frequencies
that are often encountered in daily life. The human auditory
system is most sensitive to sounds at a frequency of approxi-
mately 4000 Hz.12 In an attempt to simulate a real life situation,
we chose sound stimuli that were at, and around, this frequency.
During an acute migraine attack, SATs in allodynic patients
were, on average, 15.7 dB lower than those of non-allodynic
patients. Since the sound intensity decibel scale is logarithmic
(ie, a decrease of 10 dB in SATcorresponds to a 10-fold decreased
intensity of the aversive sound), this is a substantial difference.17 18
Between attacks, the average SAT difference between allodynic
and non-allodynic patients was smaller (5.7 dB). The biological
signiﬁcance of this SAT difference at the interictal state remains to
be determined.
We found that the average acute attack SAT decreased by
1.8 dB for every unit increase in acute headache severity
(p¼0.28). These data are in accordance with the ﬁndings of
Kelman and Tanis who showed in a large clinic based study
a correlation between headache intensity and a number of
associated symptoms, including phonophobia.19
The mechanisms of phonophobia in migraine are poorly
understood. Electrophysiological studies suggest aberrant
processing of auditory stimuli at the cortical level in these
patients.20 In these studies, that used auditory evoked potential
recordings, migraine patients exhibited lack of habituation, and
even potentiation, of the cortical response to repeated auditory
Figure 3 Allodynia scores versus
sound aversion thresholds (SATs)
during acute attacks.
Figure 4 Subjective rating of phonophobia during the acute attack, in
relation to that between attacks, in non-allodynic and allodynic patients.
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stimuli in the interictal state.21 Interestingly, lack of habituation
was also found in migraineurs in response to visual and
somatosensory stimuli.20 22 23 Data from a neuroimaging study
further support a cortical role in the development of phono-
phobia in migraine: Weiller et al found in a PET study increased
blood ﬂow in the auditory and visual association cortices (in
addition to brainstem activation) in patients with migraine
without aura during an acute attack.24 The authors suggested
that these cortical ﬁndings were related to the presence of
phonophobia and photophobia in migraine.
Allodynia in migraine is thought to result from sensitisation
of second order neurons in the trigeminal nucleus caudalis.25 As
phonophobia is probably mediated through mechanisms that
involve higher brain centres (as discussed above), it is difﬁcult to
explain an association between allodynia and phonophobia
based on a brainstem mechanism of allodynia alone. Rather, our
results suggest that the mechanisms of allodynia in migraine are
more complex, possibly involving neuronal dysfunction at
higher levels as well. These may be either thalamic or cortical, or
both. Neuroimaging studies support this notion. Witting et al, in
a PET study that used a model of capsaicin evoked pain and
allodynia, have shown that brush evoked allodynia, but not
capsaicin induced pain, activated the posterior parietal cortex,
suggesting the involvement of distinct cortical areas in the
processing of allodynia.26 In another PET study, Lorenz et al
found that the pattern of cortical representation of heat allo-
dynia was distinct from that of normal heat pain.27
Our study was limited to the evaluation of the subjective
experience of phonophobia, as reported by the subjects. The
objective correlates of this experience should be examined in
future studies. Other limitations of our study are: (1) the
investigators were not blinded to the tested subject group.
However, this probably did not have a signiﬁcant impact on our
results, for the following reasons: (a) allodynia testing was
performed before the testing of phonophobia and therefore the
examiner was not aware of subjects’ phonophobia status when
examining them for allodynia; (b) phonophobia testing was
entirely automated. (2) Determination of allodynia status of the
subjects was based on an examination during a single attack. (3)
Due to the high rate of allodynia at visit 2, the number of non-
allodynic subjects at that visit was small. (4) It has been shown
that depression and anxiety are associated with altered percep-
tion of auditory stimuli.7 28 As these psychiatric disorders are
common in migraine, their occurrence may have affected our
results. Although we cannot rule out such an effect, this is
unlikely to be a major factor in our study as none of our patients
was clinically depressed or using antidepressant drugs. (5) We
examined our patients for allodynia using brush testing, as
previously described.5 We did not test the patients for allodynia
to other sensory modalities (eg, heat, cold or pressure). In
previous studies, our method for brush allodynia testing has
proved reliable and reproducible.5 29 Furthermore, the calculated
prevalence of allodynia in our study (79%) agrees with results
obtained in studies that used quantitative sensory testing for
this purpose.4 16
In summary, our results suggest an association between
phonophobia and brush allodynia in migraine. This association
raises the possibility that the two phenomena may share
common mechanisms in migraine. Further studies are needed to
clarify these mechanisms and to examine whether similar
associations exist among other symptoms of increased sensory
aversion in migraine, such as photophobia and osmophobia.
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